144 related articles for article (PubMed ID: 16641432)
21. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
Jain R; Chen D; White RJ; Patel DV; Yuan Z
Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a human peptide deformylase: implications for antibacterial drug design.
Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
[TBL] [Abstract][Full Text] [Related]
23. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
[TBL] [Abstract][Full Text] [Related]
24. Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.
Gross M; Clements J; Beckett RP; Thomas W; Taylor S; Lofland D; Ramanathan-Girish S; Garcia M; Difuntorum S; Hoch U; Chen H; Johnson KW
J Antimicrob Chemother; 2004 Mar; 53(3):487-93. PubMed ID: 14963065
[TBL] [Abstract][Full Text] [Related]
25. Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.
Fritsche TR; Sader HS; Cleeland R; Jones RN
Antimicrob Agents Chemother; 2005 Apr; 49(4):1468-76. PubMed ID: 15793128
[TBL] [Abstract][Full Text] [Related]
26. Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells.
Apfel CM; Evers S; Hubschwerlen C; Pirson W; Page MG; Keck W
Antimicrob Agents Chemother; 2001 Apr; 45(4):1053-7. PubMed ID: 11257015
[TBL] [Abstract][Full Text] [Related]
27. Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.
Kosowska-Shick K; Credito KL; Pankuch GA; DeWasse B; McGhee P; Appelbaum PC
Antimicrob Agents Chemother; 2007 Feb; 51(2):770-3. PubMed ID: 17116666
[TBL] [Abstract][Full Text] [Related]
28. Expression, purification, and activity assay of peptide deformylase from Escherichia coli and Staphylococcus aureus.
Che X; Hu J; Wang L; Zhu Z; Xu Q; Lv J; Fu Z; Sun Y; Sun J; Lin G; Lu R; Yao Z
Mol Cell Biochem; 2011 Nov; 357(1-2):47-54. PubMed ID: 21603885
[TBL] [Abstract][Full Text] [Related]
29. N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.
Hackbarth CJ; Chen DZ; Lewis JG; Clark K; Mangold JB; Cramer JA; Margolis PS; Wang W; Koehn J; Wu C; Lopez S; Withers G; Gu H; Dunn E; Kulathila R; Pan SH; Porter WL; Jacobs J; Trias J; Patel DV; Weidmann B; White RJ; Yuan Z
Antimicrob Agents Chemother; 2002 Sep; 46(9):2752-64. PubMed ID: 12183225
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of nine peptide deformylase inhibitors and five comparator agents against respiratory and skin pathogens.
Bowker KE; Noel AR; MacGowan AP
Int J Antimicrob Agents; 2003 Dec; 22(6):557-61. PubMed ID: 14659651
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
32. Understanding the origins of time-dependent inhibition by polypeptide deformylase inhibitors.
Totoritis R; Duraiswami C; Taylor AN; Kerrigan JJ; Campobasso N; Smith KJ; Ward P; King BW; Murrayz-Thompson M; Jones AD; Van Aller GS; Aubart KM; Zalacain M; Thrall SH; Meek TD; Schwartz B
Biochemistry; 2011 Aug; 50(31):6642-54. PubMed ID: 21711014
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity.
Somerville GA; Cockayne A; Dürr M; Peschel A; Otto M; Musser JM
J Bacteriol; 2003 Nov; 185(22):6686-94. PubMed ID: 14594843
[TBL] [Abstract][Full Text] [Related]
34. Isolation and identification of FR198248, a hydroxylated 1,3-dihydroisobenzofuran, from Aspergillus flavipes as an inhibitor of peptide deformylase.
Kwon YJ; Zheng CJ; Kim WG
Biosci Biotechnol Biochem; 2010; 74(2):390-3. PubMed ID: 20139618
[TBL] [Abstract][Full Text] [Related]
35. Panosialins, inhibitors of enoyl-ACP reductase from Streptomyces sp. AN1761.
Kwon YJ; Sohn MJ; Oh T; Cho SN; Kim CJ; Kim WG
J Microbiol Biotechnol; 2013 Feb; 23(2):184-8. PubMed ID: 23412060
[TBL] [Abstract][Full Text] [Related]
36. Confirmation of the antibacterial mode of action of SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp.
Greenwood RC; Gentry DR
J Antibiot (Tokyo); 2002 Apr; 55(4):423-6. PubMed ID: 12061551
[TBL] [Abstract][Full Text] [Related]
37. Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
Credito K; Lin G; Ednie LM; Appelbaum PC
Antimicrob Agents Chemother; 2004 Oct; 48(10):4033-6. PubMed ID: 15388473
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
Licata L; Smith CE; Goldschmidt RM; Barrett JF; Frosco M
Antimicrob Agents Chemother; 1997 May; 41(5):950-5. PubMed ID: 9145850
[TBL] [Abstract][Full Text] [Related]
39. In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV.
Jones ME; Critchley IA; Karlowsky JA; Blosser-Middleton RS; Schmitz FJ; Thornsberry C; Sahm DF
Antimicrob Agents Chemother; 2002 Jun; 46(6):1651-7. PubMed ID: 12019071
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
